CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
0.7803
-0.0197 (-2.46%)
Feb 20, 2026, 12:20 PM EST - Market open
CASI Pharmaceuticals Market Cap
CASI Pharmaceuticals has a market cap or net worth of $16.03 million as of February 20, 2026. Its market cap has decreased by -59.41% in one year.
Market Cap
16.03M
Enterprise Value
30.61M
1-Year Change
-59.41%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since June 12, 1996, CASI Pharmaceuticals's market cap has decreased from $101.76M to $16.03M, a decrease of -84.24%. That is a compound annual growth rate of -6.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 16.44M | -5.88% |
| Dec 31, 2025 | 17.47M | -60.16% |
| Dec 31, 2024 | 43.84M | -54.03% |
| Dec 29, 2023 | 95.38M | 291.63% |
| Dec 30, 2022 | 24.35M | -78.22% |
| Dec 31, 2021 | 111.84M | -69.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 16.83M |
| Klotho Neurosciences | 16.46M |
| IN8bio | 16.41M |
| Citius Pharmaceuticals | 16.33M |
| Pasithea Therapeutics | 16.28M |
| Traws Pharma | 16.14M |
| Lexaria Bioscience | 16.09M |
| Intensity Therapeutics | 15.58M |